Internal Medicine, Gastroenterology · Nashville, TN
NPI
1649368366
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1211 21st Ave South, Suite 220 Mab, Vanderbilt Ibd Center
Nashville, TN, 37232
Phone (615) 936-6866
Groups this clinician bills Medicare through
Medicare paid, 2024
$29K
280 services
Medicare patients, 2024
191
Average age 69
Drug cost, 2024
$7.6M
1,151 prescriptions
Company payments, 2025
$67K
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Dawn M Borromeo Beaulieu was code 45380 (lower gi endoscopy - other), 94 times for 93 patients. In total Dawn M Borromeo Beaulieu billed 280 services in 21 codes, and Medicare paid $29K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-03-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 45380 Lower GI Endoscopy - Other | Office | 94 | 93 | $128.25 | $12K |
| 99214 Office E&M - Established | Office | 73 | 52 | $67.92 | $4,958 |
| 45385 Colonoscopy - Lesion Removal | Office | 21 | 20 | $193.89 | $4,072 |
| 99222 Hospital E&M - Initial | Facility | 20 | 20 | $101.40 | $2,028 |
| 43239 Upper GI Endoscopy | Office | 17 | 17 | $68.72 | $1,168 |
By year: 2022 $22K for 248 services; 2023 $26K for 266 services; 2024 $29K for 280 services.
Medicare prescription drug claims, 2024
In 2024, the drug Dawn M Borromeo Beaulieu prescribed most often to Medicare patients was Stelara (Ustekinumab), with 149 prescriptions and refills. In total Dawn M Borromeo Beaulieu wrote 1,151 Medicare prescriptions that cost $7.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Stelara Ustekinumab | 149 | 173 | 18 | $4.0M |
| Skyrizi On-Body Risankizumab-Rzaa | 118 | 199 | 29 | $2.3M |
| Rinvoq Upadacitinib | 90 | 102 | 13 | $672K |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 89 | 89 | 87 | $1,264 |
| Omeprazole Generic | 77 | 148 | 19 | $984 |
| Budesonide Dr Budesonide | 56 | 101 | 19 | $9,255 |
| Mesalamine Er Mesalamine | 40 | 100 | Under 11 | $13K |
| Budesonide Ec Budesonide | 33 | 66 | 12 | $10K |
| Humira(Cf) Pen Adalimumab | 31 | 31 | Under 11 | $266K |
| Mesalamine Generic | 29 | 71 | Under 11 | $26K |
| Methotrexate Methotrexate Sodium | 27 | 40 | Under 11 | $187 |
| Ondansetron Hcl Generic | 24 | 24 | 11 | $343 |
| Dicyclomine Hcl Generic | 24 | 30 | Under 11 | $573 |
| Balsalazide Disodium Generic | 24 | 54 | Under 11 | $5,394 |
| Diphenoxylate-Atropine Diphenoxylate Hcl/Atropine | 21 | 21 | Under 11 | $425 |
Brand drugs: 583 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Dawn M Borromeo Beaulieu $67K ($67K in general payments such as food, travel and fees) from 6 companies. The largest payer was Abbvie Inc. with $37K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.